28 results
8-K
EX-2.1
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
equity-related compensation, retention, bonus or incentive, severance, deferred compensation, employment, consulting, retention, executive compensation, change
424B5
STSA
Satsuma Pharmaceuticals Inc
3 Nov 22
Prospectus supplement for primary offering
4:42pm
less extensive disclosure about our executive compensation arrangements;
We will not require stockholder non-binding advisory votes on executive … disclosure requirements as those that are available to emerging growth companies, such as reduced disclosure obligations regarding executive compensation
S-3
ybqa3b91
23 Oct 20
Shelf registration
4:48pm
DEF 14A
xyxohaz09 60n
24 Apr 20
Definitive proxy
4:14pm
10-K
17u 4nzi9yu
10 Mar 20
Annual report
4:20pm
10-Q
vcf hynv1ydaoe6fsq
12 Nov 19
Quarterly report
4:31pm